Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections

Area of Science:

• Mycology
• Pharmacology
• Nanotechnology

Background:

• Invasive fungal infections pose significant global health risks, with limited treatment options due to drug bioavailability and toxicity issues.
• Voriconazole, a broad-spectrum antifungal, faces challenges with non-linear pharmacokinetics, leading to toxicity and variable efficacy.
• Nanotechnology offers a promising solution to overcome drug delivery limitations for antifungals.

Purpose of the Study:

• To review recent advancements in applying nanotechnology for voriconazole delivery.
• To evaluate how nanocarriers improve voriconazole's physicochemical and biological properties.
• To assess the potential of nanotechnology-based voriconazole formulations as safer and more effective antifungal therapies.

Main Methods:

• Literature review of studies employing nanotechnology for voriconazole drug delivery.
• Analysis of research focusing on controlled and sustained release mechanisms.
• Examination of various administration routes, including ocular, pulmonary, oral, topical, and parenteral.

Main Results:

• Nanotechnology-based systems enhance voriconazole permeation and deposition in target tissues.
• Controlled and sustained release profiles are achieved across different administration routes.
• Improved pharmacokinetic properties and reduced toxicity are observed with nanocarrier formulations.

Conclusions:

• Nanotechnology presents a viable strategy to enhance voriconazole's therapeutic potential.
• Nanocarrier-mediated delivery offers a safer and more effective alternative for treating invasive fungal infections.
• Further research into nanotech-based voriconazole delivery systems is warranted to optimize antifungal treatment.